ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION
Clinical trials for ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BNT329 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called BNT329 in people with advanced solid tumors that have a specific marker (CA19-9). The main goals are to check safety and find the best dose. About 245 participants will take part. The drug works by targeting cancer cells and may help control tum…
Matched conditions: ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New chemo combo aims to boost survival in tough esophageal cancer
Disease control Recruiting nowThis study tests whether giving two different chemotherapy regimens one after the other before surgery can help people with esophageal cancer that has spread to nearby lymph nodes. About 216 adults with resectable cancer will receive either FLOT followed by CROSS or CROSS followe…
Matched conditions: ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION
Phase: PHASE2 • Sponsor: Erasmus Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC